Routine

Palindromic rheumatism

Recurrent self-limiting arthritis · Rheumatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

A pattern of recurrent, self-limiting attacks of joint and periarticular inflammation lasting hours to days with complete resolution between episodes and no erosive damage. A substantial proportion, especially antibody-positive patients, progress to rheumatoid arthritis.

Red flags

  • Attacks becoming more frequent, prolonged or additive
  • Persistent synovitis between attacks (evolving RA)
  • Development of joint erosions
  • Systemic features suggesting connective tissue disease
  • Fever/monoarthritis raising concern for sepsis or crystals

Assessment

Differential diagnosis

  • Early rheumatoid arthritis
  • Crystal arthropathy (gout / CPPD)
  • Reactive arthritis
  • Psoriatic arthritis
  • Systemic lupus erythematosus
  • Whipple disease

Investigations

  • RF and anti-CCP (positivity predicts progression to RA)
  • CRP/ESR during and between attacks
  • Serum urate and joint aspiration if crystal disease suspected
  • Radiographs (characteristically non-erosive)
  • ANA to screen for connective tissue disease
  • Ultrasound of affected joints during attack if diagnosis unclear

Management

  • Document the episodic pattern: acute attacks with symptom-free intervals and no persistent swelling
  • Exclude crystal arthropathy and infection during an acute attack
  • Check RF and anti-CCP to stratify risk of progression to RA
  • Treat acute attacks with NSAIDs or short corticosteroid courses
  • Start hydroxychloroquine to reduce attack frequency and possibly delay progression to RA
  • Counsel antibody-positive patients about RA risk and arrange monitoring
  • Escalate to RA treatment pathway if persistent synovitis or erosions develop
  • Arrange rheumatology follow-up to detect evolution to definite RA

Drugs & doses

Naproxen — 500 mg PO BD during acute attacks (with gastroprotection)
Prednisolone — 15-20 mg PO OD short course for severe attacks
Hydroxychloroquine — 200-400 mg PO OD (max 5 mg/kg/day) to reduce attack frequency
Colchicine — 500 micrograms PO OD-BD if frequent attacks (alternative suppressive option)

Disposition

Outpatient rheumatology follow-up with antibody-based risk stratification; no admission required.

Complications & pitfalls

  • Progression to rheumatoid arthritis
  • Evolution to other connective tissue disease
  • Chronic pain and functional limitation
  • Misdiagnosis delaying DMARD therapy

Exam pearls

  • Complete resolution between attacks and no erosions distinguishes it from established RA
  • Anti-CCP and RF positivity markedly increase risk of progression to RA
  • Hydroxychloroquine reduces attack frequency and may delay RA onset
  • Peri-articular (not just articular) swelling is characteristic

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.